Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 341–360 of 1,000 recalls
Marlex Pharmaceuticals, Inc.
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Hua Da Trading, Inc. dba Wefun Inc.
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.